Mukhopadhyay D - Search Results

1

Post kala-azar dermal leishmaniasis: an unresolved mystery.

Mukhopadhyay D, Dalton JE, Kaye PM, Chatterjee M. Mukhopadhyay D, et al. Trends Parasitol. 2014 Feb;30(2):65-74. doi: 10.1016/j.pt.2013.12.004. Epub 2014 Jan 2. Trends Parasitol. 2014. PMID: 24388776 Free PMC article. Review.

2

Immunomodulation by chemotherapeutic agents against Leishmaniasis.

Saha P, Mukhopadhyay D, Chatterjee M. Saha P, et al. Among authors: mukhopadhyay d. Int Immunopharmacol. 2011 Nov;11(11):1668-79. doi: 10.1016/j.intimp.2011.08.002. Epub 2011 Aug 27. Int Immunopharmacol. 2011. PMID: 21875692 Review.

3

Miltefosine effectively modulates the cytokine milieu in Indian post kala-azar dermal leishmaniasis.

Mukhopadhyay D, Das NK, Roy S, Kundu S, Barbhuiya JN, Chatterjee M. Mukhopadhyay D, et al. J Infect Dis. 2011 Nov;204(9):1427-36. doi: 10.1093/infdis/jir551. Epub 2011 Sep 20. J Infect Dis. 2011. PMID: 21933878

4

Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.

Mukhopadhyay D, Das NK, De Sarkar S, Manna A, Ganguly DN, Barbhuiya JN, Maitra AK, Hazra A, Chatterjee M. Mukhopadhyay D, et al. Trans R Soc Trop Med Hyg. 2012 Nov;106(11):668-76. doi: 10.1016/j.trstmh.2012.07.005. Epub 2012 Aug 21. Trans R Soc Trop Med Hyg. 2012. PMID: 22920931

5

Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis.

Mukherjee S, Mukhopadhyay D, Braun C, Barbhuiya JN, Das NK, Chatterjee U, von Stebut E, Chatterjee M. Mukherjee S, et al. Among authors: mukhopadhyay d. Exp Dermatol. 2015 Mar;24(3):232-4. doi: 10.1111/exd.12635. Exp Dermatol. 2015. PMID: 25580856

6

Inadequacy of 12-Week Miltefosine Treatment for Indian Post-Kala-Azar Dermal Leishmaniasis.

Ghosh S, Das NK, Mukherjee S, Mukhopadhyay D, Barbhuiya JN, Hazra A, Chatterjee M. Ghosh S, et al. Among authors: mukhopadhyay d. Am J Trop Med Hyg. 2015 Oct;93(4):767-9. doi: 10.4269/ajtmh.14-0721. Epub 2015 Jul 14. Am J Trop Med Hyg. 2015. PMID: 26175030 Free PMC article. Clinical Trial.

7

M2 Polarization of Monocytes-Macrophages Is a Hallmark of Indian Post Kala-Azar Dermal Leishmaniasis.

Mukhopadhyay D, Mukherjee S, Roy S, Dalton JE, Kundu S, Sarkar A, Das NK, Kaye PM, Chatterjee M. Mukhopadhyay D, et al. PLoS Negl Trop Dis. 2015 Oct 23;9(10):e0004145. doi: 10.1371/journal.pntd.0004145. eCollection 2015 Oct. PLoS Negl Trop Dis. 2015. PMID: 26496711 Free PMC article.

8

A male preponderance in patients with Indian post kala-azar dermal leishmaniasis is associated with increased circulating levels of testosterone.

Mukhopadhyay D, Mukherjee S, Ghosh S, Roy S, Saha B, Das NK, Chatterjee M. Mukhopadhyay D, et al. Int J Dermatol. 2016 May;55(5):e250-5. doi: 10.1111/ijd.13048. Epub 2015 Nov 4. Int J Dermatol. 2016. PMID: 26536363

9

Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis.

Mukherjee S, Mukhopadhyay D, Ghosh S, Barbhuiya JN, Das NK, Chatterjee M. Mukherjee S, et al. Among authors: mukhopadhyay d. J Clin Immunol. 2016 Jan;36(1):85-94. doi: 10.1007/s10875-015-0215-8. Epub 2015 Dec 7. J Clin Immunol. 2016. PMID: 26644312

10

Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis.

Ganguly S, Mukhopadhyay D, Das NK, Chaduvula M, Sadhu S, Chatterjee U, Rahman M, Goswami RP, Guha SK, Modak D, Mallik S, Gonju D, Pramanik N, Barbhuiya JN, Saha B, Chatterjee M. Ganguly S, et al. Among authors: mukhopadhyay d. J Invest Dermatol. 2010 Apr;130(4):1013-22. doi: 10.1038/jid.2009.393. Epub 2009 Dec 24. J Invest Dermatol. 2010. PMID: 20032994 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

641 results

Search Page